Immunology Drugmaker Electra Seeks to Raise $347 Million in IPO
The clinical-stage developer of immunology drugs plans to raise up to $347 million through a US initial public offering.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
This story has stopped developing; this page is its permanent record. More from that day
The story so far
1 publisher has covered this in 2 articles since 14 Sept 2026. Bloomberg.com published first, on 14 September at 10:40 UTC. The most recent article, from Bloomberg Technology, appeared on 15 September at 11:25 UTC.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- Electra Therapeutics Inc.